Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 10, 2025 10:00 ET | Source: 4D Path

4D Path Collaborates with AMD and Oracle to Scale Predictive Oncology

4D Path has announced a collaboration with AMD and Oracle to advance predictive oncology and accelerate clinical trials.
December 09, 2025 05:23 ET | Source: Research and Markets

DNA Diagnostics Market Projected to Surge by 66% to USD 21.69 Billion by 2030

Dublin, Dec. 09, 2025 (GLOBE NEWSWIRE) -- The "DNA Diagnostics Market - Global Outlook & Forecast 2025-2030" has been added to ResearchAndMarkets.com's offering.The DNA Diagnostics Market was...
December 03, 2025 10:00 ET | Source: 4D Path

4D Path’s Physics-Inspired QPOR™ Platform Predicts Neoadjuvant Chemotherapy Response from Routine Biopsy Images in Early-Stage Triple-Negative Breast Cancer from Phase II TBCRC-030 Trial

Trial analysis published in JNCI predicts residual cancer burden from baseline H&E slides using 4D Path's fully automated, treatment predictive platform
November 26, 2025 12:09 ET | Source: Research and Markets

Cancer Diagnostics Market Intelligence Report 2025-2032: Technologies, Applications, End-Use Facilities and the Competition

Dublin, Nov. 26, 2025 (GLOBE NEWSWIRE) -- The "Cancer Diagnostics Market - Technologies, Applications and End-Use Facilities" has been added to ResearchAndMarkets.com's offering.The cutting-edge...
November 26, 2025 07:25 ET | Source: Research and Markets

Cancer Diagnostic Collaboration and Licensing Agreements Trends Analysis Report 2025 with Directory of 724 Deals Signed Since 2018 by Company A-Z, Therapy Focus and Technology Type

Dublin, Nov. 26, 2025 (GLOBE NEWSWIRE) -- The "Cancer Diagnostic Collaboration and Licensing Deals 2018-2025" has been added to ResearchAndMarkets.com's offering.This report contains a...
September 30, 2025 04:00 ET | Source: MSInsight

MSInsight se joint au projet PREDI-LYNCH, une initiative européenne pour permettre d’identifier plus tôt les porteurs du syndrome de Lynch, l’une des principales prédispositions héréditaires au cancer.

Communiqué de presse Paris, 29 septembre 2025 – MSInsight, start-up française de médecine de précision en oncologie, annonce sa participation au projet européen PREDI-LYNCH, un consortium...
September 30, 2025 04:00 ET | Source: MSInsight

MSInsight Joins PREDI-LYNCH Project to Advance Non-Invasive Cancer Detection in Lynch Syndrome — Aligning With Hereditary Cancer Awareness Week

Press Release Paris, September 2025 – MSInsight, a French precision oncology start-up, is proud to announce its participation in PREDI-LYNCH*, a six-year Horizon Europe consortium led by Oslo...
September 22, 2025 08:00 ET | Source: Onconetix, Inc.

Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM

CINCINNATI, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) ("Onconetix" or the “Company”) a commercial stage biotechnology company focused on the research, development and...
September 19, 2025 09:00 ET | Source: SNS Insider pvt ltd

Carcinoembryonic Antigen Market Size to Reach Around US$ 3.45 Billion By 2033, Driven by Growing Cancer Burden and Personalized Medicine | S&S Insider

Austin, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Carcinoembryonic Antigen Market Size Analysis: According to S&S Insider Research, the Carcinoembryonic Antigen Market was valued at USD 2.17 billion...
September 08, 2025 11:14 ET | Source: Research and Markets

Canine Cancer Screening Market Report 2025: IDEXX Laboratories, Zoetis, and Heska Corporation Lead this Rapidly Evolving Industry

Dublin, Sept. 08, 2025 (GLOBE NEWSWIRE) -- The "Canine Cancer Screening Market by Product Type, Technology, End User, Cancer Type, Sample Type and Region - Global Forecast 2025-2030" has been added...